Navigation Links
Composite fillings to hasten work procedures

Amorphous calcium phosphate is showing great covenant in dental restorative work, say researchers at the National Institute of Standards and Technology at Ohio.//This ACP has new physical-chemical properties,” says Tyndall Don, Ph.D., a researcher at OSU. “It’s more soluble than other calcium phosphates and has a tendency to convert to the stable dental mineral hydroxyapatite, which is the main inorganic component of teeth.”

The product is biocompatible and has remineralization potential, he explains. Simply put, it re-deposits the hydroxyapatite in areas of the tooth damaged by decay — caries — helping the tooth structure to repair itself.ACP has been around for decades, but this new compound has the unique ability to incorporate with photocurable polymer composite resins — making it stable or degradable, depending on your intended application.

The most proximate application of nonbiodegradable ACP would be in orthodontics. Mixing it into the adhesive would prevent cavities from forming around the orthodontic brace via remineralization, or at least would inhibit demineralization.

Another use is as a base material, or liner, underneath the regular filling. This would stop secondary cavities from forming around the original cavity under or adjacent to the filling. Dr. Don calls this a major advancement since more than half of fillings are necessitated by secondary tooth decay.

“Compared with conventional composites, the ACP is weaker mechanically and cannot be used for major restorations,” says Dr. Don. “We are working on improvement of mechanical properties by modifying the surface properties of ACP and by changing the composition of the resin," he says.br>

'"/>




Page: 1

Related medicine news :

1. Mercury fillings during pregnancy may not lead to low birth weight
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Chronic binge drinking can hasten HIV development
4. Benefits in fertility procedures
5. Survival rate not improved by invasive procedures
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, a ... communities across North Carolina, is launching a charity event in conjunction with the ... the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network (BCAN) ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Donna Bergman, professor of ... and published an article in the medical science journal Physical Medicine and Rehabilitation ... article and the research that helped produce it, were written and conducted in ...
(Date:7/25/2017)... WI (PRWEB) , ... July 25, 2017 , ... ... Aloria Health, as medical director. Dr. Negrette has more than a decade of ... She has worked closely with individuals fighting addictions, eating disorders, psychotic and manic ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... Product Innovation in the prestigious CEO World Awards®. The coveted annual CEO World ... and services, CEO case studies, corporate social responsibility, and milestones from every major ...
(Date:7/24/2017)... PARK (PRWEB) , ... July 24, 2017 , ... Engineers ... is bio-compatible, because it produces the same kind of electrical energy that the body ... the form of moving electrons. This flow of electrons out of the battery is ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
Breaking Medicine Technology: